# Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome

> **NCT00947713** · PHASE1,PHASE2 · COMPLETED · sponsor: **Royan Institute** · enrollment: 10 (actual)

## Conditions studied

- Endocrine System Diseases
- Gonadal Disorders

## Interventions

- **DRUG:** low dose human chorionic gonadotropin
- **DRUG:** Clomiphen citrate plus HMG

## Key facts

- **NCT ID:** NCT00947713
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-08
- **Final completion:** 2010-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2011-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947713, "Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00947713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*